Kathmandu, Nepal – October 30, 2024 – CRS Healthcare, a leading distributor of health products in Nepal, is excited to announce a strategic partnership with Novala Biotech. Noval Biotech is Nepal’s leading biotechnology company specialized in the development and manufacturing of in-vitro diagnostic kits, including for pregnancy, fertility, dengue, malaria, hepatitis and HIV testing. This collaboration aims to enhance accessibility of quality healthcare commodities across the nation.
As the sole distributor of Novala Biotech’s innovative health kits in Nepal, CRS Healthcare is poised to providing cutting-edge diagnostic solutions to various health and fertility conditions, including pregnancy and fertility. These easy-to-use and high-quality diagnostic kits will empower healthcare professionals and individuals to promoting better health and well-being for all.
This partnership aligns with CRS Healthcare’s mission to improve public health by providing accessible and reliable healthcare solutions. By combining Novala Biotech’s advanced technology with CRS Healthcare’s strong distribution network, the two companies are committed to making a significant impact on Nepal’s healthcare landscape.
CRS Chowk, Tokharoad, Kathmandu, Nepal